UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma

Cancer ◽  
2008 ◽  
Vol 112 (9) ◽  
pp. 1932-1940 ◽  
Author(s):  
Chun-Yu Liu ◽  
Po-Min Chen ◽  
Tzeon-Jye Chiou ◽  
Jin-Hwang Liu ◽  
Jen-Kou Lin ◽  
...  
Keyword(s):  
Treatment Outcome ◽  
Colorectal Carcinoma ◽  
Metastatic Colorectal Carcinoma

Tc-99m DMSA Uptake by Metastatic Colorectal Carcinoma

2004 ◽  
Vol 29 (8) ◽  
pp. 485-487 ◽  
Author(s):  
Phivi Rondogianni ◽  
George Koniaris
Keyword(s):  
Colorectal Carcinoma ◽  
Metastatic Colorectal Carcinoma

scholarly journals Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study

HPB ◽  
2010 ◽  
Vol 12 (1) ◽  
pp. 31-36 ◽  
Author(s):  
Matthew Bower ◽  
Tiffany Metzger ◽  
Ken Robbins ◽  
Dana Tomalty ◽  
Vlatimil Válek ◽  
...  
Keyword(s):  
Adjuvant Therapy ◽  
Colorectal Carcinoma ◽  
Metastatic Colorectal Carcinoma ◽  
Drug Eluting Beads ◽  
Drug Eluting

scholarly journals The Randomized Phase 3 Impala Study: Immunomodulatory Maintenance Therapy with TLR-9 Agonist MGN1703 in Patients with Metastatic Colorectal Carcinoma

2014 ◽  
Vol 25 ◽  
pp. ii98
Author(s):  
Cunningham David ◽  
Zurlo Alfredo ◽  
Salazar Ramon ◽  
Ducreux Michel ◽  
Waddell Tom ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Maintenance Therapy ◽  
Metastatic Colorectal Carcinoma ◽  
Phase 3

A Phase I Study of Cisplatinum plus 5-Fluorouracil in Modulation with Citrovorum Factor in Metastatic Colorectal Carcinoma

1991 ◽  
Vol 3 (3) ◽  
pp. 170-175 ◽  
Author(s):  
S. Palmeri ◽  
V. Gebbia ◽  
A. Russo ◽  
N. Gebbia ◽  
Y. Rustum ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Colorectal Carcinoma
Sign in / Sign up

Export Citation Format

Share Document